Nanotechnology approach in tuberculosis

Nanotechnology is duplicating the matter on an atomic scale. Nanotechnology refers to building the structure in micro level. Development of novel drugs decreases the drug resistance and drug interaction. In the past years many research are done in developing the nanotechnology based therapy for replacing the administration of antibiotics. Different animal model are tired to develop antibiotic therapy using polymer technology. Nanoparticles are made up of biocompatible and biodegradable which is either natural or synthetic .they can easily dissolve in cell .polymeric nanoparticles represent as bio adhesive in gastro intestinal tract. Poly lactic-co-glycolic acid [PLGA] is a copolymer accepted by food and drug administration for therapeutic purpose. Nano beads have the slow and sustained release of particles. Introduction of nanoparticles allows decreasing the side effects, multiple drugs can be encapsulated in a matrix, high constancy.

 

  • Nanotechnology based therapy
  • Oral delivery of ATD nanomedicine
  • Nano suspensions and emulsions
  • Encapsulation of anti-tuberculosis drugs
  • Polymeric nanoparticles

Related Conference of Nanotechnology approach in tuberculosis

June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

Singapore
October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
November 05-06, 2020

9th Asia Pacific STD and Infectious Diseases Congress

Tokyo, Japan
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
February 22-23, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore

Nanotechnology approach in tuberculosis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in